FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2992600517> ?p ?o ?g. }

• W2992600517 endingPage "1958" @default.
• W2992600517 startingPage "1958" @default.
• W2992600517 abstract "The role of Notch signaling in acute myeloid leukemia (AML) is still under investigation. We have previously shown that high levels of Notch receptors and ligands could interfere with drug response. In this study, the protein expression of 79 AML blast samples collected from newly diagnosed patients was examined through flow cytometry. Gamma-secretase inhibitors were used in AML mouse xenograft models to evaluate the contribution of Notch pharmacological inhibition to mouse survival. We used univariate analysis for testing the correlation and/or association between protein expression and well-known prognostics markers. All the four receptors (Notch1–4) and some ligands (Jagged2, DLL-3) were highly expressed in less mature subtypes (M0–M1). Notch3, Notch4, and Jagged2 were overexpressed in an adverse cytogenetic risk group compared to good cytogenetic risk patients. Chi-square analysis revealed a positive association between the complete remission rate after induction therapy and weak expression of Notch2 and Notch3. We also found an association between low levels of Notch4 and Jagged2 and three-year remission following allogeneic stem cell transplantation (HSCT). Accordingly, Kaplan–Meier analysis showed improved OS for patients lacking significant expression of Notch4, Jagged2, and DLL3. In vivo experiments in an AML mouse model highlighted both improved survival and a significant reduction of leukemia cell burden in the bone marrow of mice treated with the combination of Notch pan-inhibitors (GSIs) plus chemotherapy (Ara-C). Our results suggest that Notch can be useful as a prognostic marker and therapeutic target in AML." @default.
• W2992600517 created "2019-12-13" @default.
• W2992600517 creator A5005050372 @default.
• W2992600517 creator A5009027370 @default.
• W2992600517 creator A5026258863 @default.
• W2992600517 creator A5027138563 @default.
• W2992600517 creator A5041326568 @default.
• W2992600517 creator A5063615908 @default.
• W2992600517 creator A5066472200 @default.
• W2992600517 creator A5070044155 @default.
• W2992600517 creator A5071326227 @default.
• W2992600517 creator A5084153000 @default.
• W2992600517 creator A5089037074 @default.
• W2992600517 date "2019-12-06" @default.
• W2992600517 modified "2023-10-17" @default.
• W2992600517 title "Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia" @default.
• W2992600517 cites W1977561732 @default.
• W2992600517 cites W1997772586 @default.
• W2992600517 cites W2008295869 @default.
• W2992600517 cites W2016100326 @default.
• W2992600517 cites W2022507945 @default.
• W2992600517 cites W2022593879 @default.
• W2992600517 cites W202369197 @default.
• W2992600517 cites W2056638182 @default.
• W2992600517 cites W2058213712 @default.
• W2992600517 cites W2080737906 @default.
• W2992600517 cites W2088720735 @default.
• W2992600517 cites W2102423175 @default.
• W2992600517 cites W2113096952 @default.
• W2992600517 cites W2113473901 @default.
• W2992600517 cites W2291477165 @default.
• W2992600517 cites W2339658711 @default.
• W2992600517 cites W2340611212 @default.
• W2992600517 cites W2346775209 @default.
• W2992600517 cites W2419558864 @default.
• W2992600517 cites W2509517672 @default.
• W2992600517 cites W2549222926 @default.
• W2992600517 cites W2616284760 @default.
• W2992600517 cites W2725261266 @default.
• W2992600517 cites W2769373950 @default.
• W2992600517 cites W2795822432 @default.
• W2992600517 cites W2796127234 @default.
• W2992600517 cites W2802099989 @default.
• W2992600517 cites W2884048003 @default.
• W2992600517 cites W2888507943 @default.
• W2992600517 cites W2904456334 @default.
• W2992600517 cites W2907793916 @default.
• W2992600517 cites W2910094916 @default.
• W2992600517 cites W2910841031 @default.
• W2992600517 cites W2925631060 @default.
• W2992600517 cites W4231346141 @default.
• W2992600517 doi "https://doi.org/10.3390/cancers11121958" @default.
• W2992600517 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6966525" @default.
• W2992600517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31817634" @default.
• W2992600517 hasPublicationYear "2019" @default.
• W2992600517 type Work @default.
• W2992600517 sameAs 2992600517 @default.
• W2992600517 citedByCount "19" @default.
• W2992600517 countsByYear W29926005172020 @default.
• W2992600517 countsByYear W29926005172021 @default.
• W2992600517 countsByYear W29926005172022 @default.
• W2992600517 countsByYear W29926005172023 @default.
• W2992600517 crossrefType "journal-article" @default.
• W2992600517 hasAuthorship W2992600517A5005050372 @default.
• W2992600517 hasAuthorship W2992600517A5009027370 @default.
• W2992600517 hasAuthorship W2992600517A5026258863 @default.
• W2992600517 hasAuthorship W2992600517A5027138563 @default.
• W2992600517 hasAuthorship W2992600517A5041326568 @default.
• W2992600517 hasAuthorship W2992600517A5063615908 @default.
• W2992600517 hasAuthorship W2992600517A5066472200 @default.
• W2992600517 hasAuthorship W2992600517A5070044155 @default.
• W2992600517 hasAuthorship W2992600517A5071326227 @default.
• W2992600517 hasAuthorship W2992600517A5084153000 @default.
• W2992600517 hasAuthorship W2992600517A5089037074 @default.
• W2992600517 hasBestOaLocation W29926005171 @default.
• W2992600517 hasConcept C126322002 @default.
• W2992600517 hasConcept C143998085 @default.
• W2992600517 hasConcept C144301174 @default.
• W2992600517 hasConcept C161879069 @default.
• W2992600517 hasConcept C170493617 @default.
• W2992600517 hasConcept C203014093 @default.
• W2992600517 hasConcept C2778461978 @default.
• W2992600517 hasConcept C2778729363 @default.
• W2992600517 hasConcept C2779282312 @default.
• W2992600517 hasConcept C2780007613 @default.
• W2992600517 hasConcept C38180746 @default.
• W2992600517 hasConcept C502942594 @default.
• W2992600517 hasConcept C71924100 @default.
• W2992600517 hasConcept C86803240 @default.
• W2992600517 hasConceptScore W2992600517C126322002 @default.
• W2992600517 hasConceptScore W2992600517C143998085 @default.
• W2992600517 hasConceptScore W2992600517C144301174 @default.
• W2992600517 hasConceptScore W2992600517C161879069 @default.
• W2992600517 hasConceptScore W2992600517C170493617 @default.
• W2992600517 hasConceptScore W2992600517C203014093 @default.
• W2992600517 hasConceptScore W2992600517C2778461978 @default.
• W2992600517 hasConceptScore W2992600517C2778729363 @default.
• W2992600517 hasConceptScore W2992600517C2779282312 @default.

• next